# FDA Inspection 981277 - Biomat USA Inc - June 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/71ad1ff9-7ae2-45dc-9e4e-68e38e7a6cce
Source feed: FDA_Inspections

> FDA Inspection 981277 for Biomat USA Inc on June 21, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 981277
- Company Name: Biomat USA Inc
- Inspection Date: 2016-06-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1111584 - 2019-10-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ee67277e-9149-421a-94a9-fa056bb0d495)
- [FDA Inspection 1029272 - 2017-08-29](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/361f2001-62b6-4496-9eec-664836e4bd57)
- [FDA Inspection 869727 - 2014-03-11](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/97ae92cd-6f58-4c8f-97a3-dd712cbe2aa2)
- [FDA Inspection 756129 - 2011-10-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4b09699a-c7af-4e8f-84e4-8f2030dc5949)

Company: https://www.keypedia.com/companies/biomat-usa-inc/f4246f7c-dd27-450c-a8f8-ea73caedb0dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d